Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$162.70

-7.45 (-4.38%)

08:35
04/09/18
04/09
08:35
04/09/18
08:35

Technical Take: Bluebird Bio trades higher in pre-market

The stock was last up over 4.1% to $169.50. At that price next resistance is at $171.10. Support is at $167.80.

  • 08

    May

BLUE Bluebird Bio
$162.70

-7.45 (-4.38%)

03/14/18
JANY
03/14/18
INITIATION
Target $220
JANY
Neutral
Bluebird Bio initiated with a Neutral at Janney Capital
Janney Capital initiated Bluebird Bio with a Neutral rating and $220 fair value estimate.Target $220.
03/16/18
03/16/18
INITIATION

Bluebird Bio initiated with a Sell at Favus
03/21/18
MSCO
03/21/18
NO CHANGE
Target $209
MSCO
Equal Weight
Bluebird Bio price target to $209 from $152 at Morgan Stanley
Morgan Stanley analyst Matthew Harrison raised his price target on Bluebird Bio (BLUE) to $209 from $152, stating that he now expects BCMA therapies to take 50% of the third line market by 2030 and noting that bb2121 has 50% market share there. The new assumptions increase his peak sales forecast to about $2.6B from about $1B, he pointed out. However, Harrison keeps an Equal Weight rating on Bluebird, stating that he would expect new data to be available at ASCO in June, but would also expect to see competitor data potentially from Celgene's (CELG) Juno, Gilead's (GILD) Kite, Johnson & Johnson's (JNJ) Nanjing Legend and others.
03/28/18
03/28/18
NO CHANGE

Bluebird Bio and Celegene to co-develop bb2121 anti-BMCA therapy
Bluebird Bio (BLUE) and Celgene (CELG) announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen, or BCMA chimeric antigen receptor, or CAR, T cell therapy for the potential treatment of patients with relapsed/refractory multiple myeloma in the United States.The companies originally entered into a broad, global strategic research collaboration in 2013 to discover, develop and commercialize novel therapies in oncology, which included bb2121.

TODAY'S FREE FLY STORIES

HES

Hess Corp.

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Downgrade
Hess Corp. rating change  »

Hess Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

UPLD

Upland Software

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Hot Stocks
Upland Software partners with Thavron Solutions for IT management »

Upland Software announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 29

    May

  • 12

    Jun

BKU

BankUnited

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Upgrade
BankUnited rating change  »

BankUnited upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Hot Stocks
Breaking Hot Stocks news story on UPS »

UPS says confident a deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

COP

ConocoPhillips

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Downgrade
ConocoPhillips rating change  »

ConocoPhillips downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 07

    May

  • 22

    May

  • 30

    May

ABBV

AbbVie

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says 'highly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

AAL

American Airlines

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
Breaking Hot Stocks news story on American Airlines »

American Airlines: EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Jun

PLUS

ePlus

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
ePlus ePlus announces 500,000 share stock repurchase program »

ePlus announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Hot Stocks
Land & Buildings sends letter to Taubman Centers shareholders »

Land & Buildings sent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RTN

Raytheon

, LMT

Lockheed Martin

$329.23

-7.14 (-2.12%)

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Recommendations
Raytheon, Lockheed Martin, General Dynamics, Northrop Grumman analyst commentary  »

Defense weakness due to…

RTN

Raytheon

LMT

Lockheed Martin

$329.23

-7.14 (-2.12%)

GD

General Dynamics

$214.53

-7.51 (-3.38%)

NOC

Northrop Grumman

$333.06

-7.94 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

ALGT

Allegiant Travel

$143.35

-0.1 (-0.07%)

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Upgrade
Allegiant Travel rating change  »

Allegiant Travel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLB

Columbia Banking

$44.76

0.05 (0.11%)

09:14
04/26/18
04/26
09:14
04/26/18
09:14
Earnings
Columbia Banking reports Q1 EPS 55c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

FB

Facebook

$159.69

0.03 (0.02%)

09:14
04/26/18
04/26
09:14
04/26/18
09:14
Recommendations
Facebook analyst commentary  »

Facebook remains favorite…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEN

Sientra

$12.91

-0.88 (-6.38%)

09:11
04/26/18
04/26
09:11
04/26/18
09:11
Recommendations
Sientra analyst commentary  »

Sientra price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAH

Booz Allen

$39.82

-0.31 (-0.77%)

09:11
04/26/18
04/26
09:11
04/26/18
09:11
Hot Stocks
Booz Allen is added to $998M contract award from the AFMC »

The 96 Test Wing verifies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 29

    May

CFR

Cullen/Frost

$109.66

0.22 (0.20%)

09:11
04/26/18
04/26
09:11
04/26/18
09:11
Earnings
Cullen/Frost reports Q1 EPS $1.61, consensus $1.48 »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

09:10
04/26/18
04/26
09:10
04/26/18
09:10
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

ABBV

AbbVie

$91.91

0.57 (0.62%)

09:09
04/26/18
04/26
09:09
04/26/18
09:09
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

SCG

Scana

$36.56

0.78 (2.18%)

09:09
04/26/18
04/26
09:09
04/26/18
09:09
Upgrade
Scana rating change  »

Scana upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSL

MidSouth Bancorp

$13.45

-0.15 (-1.10%)

09:08
04/26/18
04/26
09:08
04/26/18
09:08
Earnings
MidSouth Bancorp reports Q1 adj. EPS 21c, consensus (8c) »

Reports Q1 tier 1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

F

Ford

$11.11

0.16 (1.46%)

09:08
04/26/18
04/26
09:08
04/26/18
09:08
Recommendations
Ford analyst commentary  »

Ford showing urgency to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

MTH

Meritage Homes

$43.43

0.625 (1.46%)

09:08
04/26/18
04/26
09:08
04/26/18
09:08
Recommendations
Meritage Homes analyst commentary  »

Meritage Homes price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MATR

Mattersight

$2.15

-0.1 (-4.44%)

, NICE

Nice Systems

$93.85

-1.34 (-1.41%)

09:07
04/26/18
04/26
09:07
04/26/18
09:07
Recommendations
Mattersight, Nice Systems analyst commentary  »

Lake Street does not…

MATR

Mattersight

$2.15

-0.1 (-4.44%)

NICE

Nice Systems

$93.85

-1.34 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 29

    May

GM

General Motors

$38.10

0.18 (0.47%)

09:07
04/26/18
04/26
09:07
04/26/18
09:07
Earnings
GM continues to see FY18 adjusted EPS in 'mid-$6' range, consensus $6.33 »

GM continues to project…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 20

    Jun

ORI

Old Republic

$21.22

-0.075 (-0.35%)

09:07
04/26/18
04/26
09:07
04/26/18
09:07
Earnings
Old Republic reports Q1 EPS 1c, may not compare to consensus 41c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.